Leukemia, Myelodysplasia, Transplantation
News
Ibrutinib associated with decreased circulating malignant cells and restored T-cell function in CLL patients
News
Beat AML: Precision medicine strategy feasible, superior to SOC for AML
"The study is changing significantly the way we look at treating patients with AML, showing that precision medicine ... can improve short- and...
Conference Coverage
Novel agents hold promise for frontline AML treatment
Conference Coverage
Final ASCEND study data: Acalabrutinib beat standard of care for r/r CLL
News
ESMO offers new clinical practice guideline for CLL
Conference Coverage
Can AML patients be too old for cell transplantation?
Opinion
The scope of under- and overtreatment in older adults with cancer
News
Two new protein biomarkers may serve as prognostic indicators for outcomes in CLL
Study also validated the prognostic value of two previously studied biomarkers.
Conference Coverage
Survey quantifies COVID-19’s impact on oncology
Oncologists detail how COVID-19 has impacted care, caregivers, continuing medical education, and clinical trials.
Article
COVID-19 prompts ‘democratization’ of cancer trials
Dr. Alan Lyss reviews a panel discussion about how COVID-19 has affected cancer research.
